Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The treatment combination is effective and generally safe for lung cancer.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

PLD is an effective and safer alternative for treating breast cancer.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Promising cancer treatments were found, but the manufacturer closed.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.